IM Cannabis Raises US$1,200,000 of Gross Proceeds in Convertible Note Financing

IM Cannabis closed a US$1.2 million private-placement convertible note with a 15% original issue discount, 4% annual interest (14% after a continuing event of default), and a 28-month maturity. The note converts at the lower of US$0.610 per share or 85% of the lowest daily VWAP over the prior 20 trading days, subject to a US$0.1449 floor; the investor also received warrants for 3,936,330 shares at US$0.610. Proceeds are intended for general corporate purposes, and the company may request up to US$1.2 million in additional notes per three-month period starting January 1, 2027.

Analysis

IMCC — financing quality and dilution path. The immediate benefit is incremental liquidity, but the structure makes future equity supply price-sensitive: conversion at a discount to recent VWAP can create a feedback loop in which weakness lowers the conversion price, increases shares issued for a given balance, and pressures subsequent VWAPs. The floor limits that mechanism but does not remove dilution risk. Warrants and anti-dilution terms add contingent supply; without the current share count and note-conversion details, the potential ownership impact cannot be sized. The 15% original issue discount also means stated principal overstates cash received: roughly $1.02 million before fees if the discount is applied to the full face amount.

Horizon and catalysts. Near term, the financing reduces immediate liquidity pressure, but is not evidence of improving operating economics. From January 2027, the possible quarterly follow-on notes may provide a funding bridge, not committed capital; reliance on repeat issuance could keep an equity overhang in place. Watch resale-registration effectiveness, conversion notices, cash burn, and whether the company can meet the later installment schedule. Israel operating disruption or weaker sales could make the financing path more dilutive. Conversely, sustained cash generation and no conversions would weaken the bearish supply thesis.

Contrarian read. This is not automatically a near-term short: the existing investor’s participation and added liquidity may support the shares initially, while a low-priced, potentially illiquid security can squeeze. The more durable signal is financing dependence, not proof of imminent default. Confirm outstanding shares, cash runway, other debt maturities, trading liquidity/borrow, and actual conversion activity before sizing exposure.

Key Decisions for Investors

• Treat IMCC as an avoid/underweight rather than chase a relief rally; the financing buys time but leaves dilution and repayment risks unresolved.
• Do not initiate an outright short solely on the announcement. Reassess after resale-registration effectiveness or disclosed conversions, and only if borrow availability and liquidity support an executable position.
• Set an alert for quarterly cash burn, cash balance, other debt maturities, shares outstanding, and conversion notices. Evidence of runway extending without new issuance would falsify the persistent-dilution thesis; repeated discounted conversions would reinforce it.